default author photo

Charles-Hugo Marquette

Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology

Nice

France

  • Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology

SCHOLARLY PAPERS

2

DOWNLOADS

122

TOTAL CITATIONS

3

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Circulating Tumor Cells as a Potential Biomarker for Lung Cancer Screening: Results of the AIR Study

Number of pages: 23 Posted: 13 Dec 2019
Charles-Hugo Marquette, Jacques Boutros, Jonathan Benzaquen, Marion Ferreira, Jean Pastre, Christophe Pison, Bernard Padovani, Faiza Bettayeb, Vincent Fallet, Nicolas Guibert, Damien Basille, Catherine Butori, Marius Ilie, Véronique Hofman, Paul Hofman and AIR project Study Group
Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Cote d'Azur - Department of Pulmonary Medicine and Oncology, Université Cote d'Azur - Department of Pulmonary Medicine and Oncology, CHRU Tours, University of Paris - Georges Pompidou European Hospital, University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), Université Côte d'Azur, CHU de Marseille, Sorbonne University, Université de Toulouse - CHU Toulouse-Purpan, Université d'Amiens - Centre Hospitalier Universitaire, Université Côte d'Azur, Université Côte d'Azur, Université Côte d'Azur, Nice University Hospital - Laboratory of Clinical and Experimental Pathology and Independent
Downloads 72 (860,052)
Citation 3

Abstract:

Loading...

Lung cancer; screening; biomarker; circulating tumor cells

2.

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients

Number of pages: 21 Posted: 13 Dec 2021
Emanuela Martinuzzi, Jonathan Benzaquen, Olivier Guerin, Sylvie Leroy, Thomas Simon, Marius Ilie, Véronique Hofman, Maryline Allegra, Virginie Tanga, Emeline Michel, Jacques Boutros, Charlotte Maniel, Antoine Sicard, Nicolas Glaichenhaus, Cecil Czerkinsky, Philippe Blancou, Paul Hofman and Charles-Hugo Marquette
Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur - Autonomy Aging Rehabilitation Department, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur - Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur - Autonomy Aging Rehabilitation Department, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN) and Université Côte d'Azur - Department of Pulmonary Medicine and Thoracic Oncology
Downloads 50 (1,063,489)

Abstract:

Loading...

mucosal immunity, secretory antibodies, SARS-CoV-2, COVID-19 mRNA vaccine